{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:40:06Z","timestamp":1735328406022,"version":"3.32.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,27]]},"DOI":"10.7759\/cureus.76479","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:01:02Z","timestamp":1735326062000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Contributing Risk Factors Leading to Heart Failure in Patients Who Are Methamphetamine Users"],"prefix":"10.7759","author":[{"given":"Magnus","family":"To","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Savoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napatkamon","family":"Ayutyanont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vandeveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2022","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD; 2022. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt39443\/2021NSDUHFFRRev010323.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3758","article-title":"Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States","volume":"1","author":"Winkelman TN","year":"2018","unstructured":"Winkelman TN, Admon LK, Jennings L, Shippee ND, Richardson CR, Bart G. Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States. JAMA Netw Open. 2018, 1:e183758. 10.1001\/jamanetworkopen.2018.3758","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.10.006","article-title":"Clinical characteristics and outcome of methamphetamine-associated pulmonary arterial hypertension and dilated cardiomyopathy","volume":"6","author":"Zhao SX","year":"2018","unstructured":"Zhao SX, Kwong C, Swaminathan A, Gohil A, Crawford MH. Clinical characteristics and outcome of methamphetamine-associated pulmonary arterial hypertension and dilated cardiomyopathy. JACC Heart Fail. 2018, 6:209-18. 10.1016\/j.jchf.2017.10.006","journal-title":"JACC Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2015.10.019","article-title":"The cardiac complications of methamphetamines","volume":"25","author":"Paratz ED","year":"2016","unstructured":"Paratz ED, Cunningham NJ, MacIsaac AI. The cardiac complications of methamphetamines. Heart Lung Circ. 2016, 25:325-32. 10.1016\/j.hlc.2015.10.019","journal-title":"Heart Lung Circ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Yeo KK","year":"2007","unstructured":"Yeo KK, Wijetunga M, Ito H, et al.. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007, 120:165-71. 10.1016\/j.amjmed.2006.01.024","journal-title":"Am J Med"},{"key":"ref6","article-title":"Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm","volume":"19","author":"Chen JP","year":"2007","unstructured":"Chen JP. Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm. J Invasive Cardiol. 2007, 19:E89-92.","journal-title":"J Invasive Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.07.001","article-title":"Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study","volume":"179","author":"Darke S","year":"2017","unstructured":"Darke S, Duflou J, Kaye S. Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study. Drug Alcohol Depend. 2017, 179:174-9. 10.1016\/j.drugalcdep.2017.07.001","journal-title":"Drug Alcohol Depend"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40199-017-0170-4","article-title":"Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths","volume":"25","author":"Akhgari M","year":"2017","unstructured":"Akhgari M, Mobaraki H, Etemadi-Aleagha A. Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. Daru. 2017, 25:5. 10.1186\/s40199-017-0170-4","journal-title":"Daru"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.101042","article-title":"Is methamphetamine-linked cardiomyopathy an emerging epidemic for new generation?","volume":"48","author":"Latif A","year":"2023","unstructured":"Latif A, Ahsan MJ, Lateef N, et al.. Is methamphetamine-linked cardiomyopathy an emerging epidemic for new generation?. Curr Probl Cardiol. 2023, 48:101042. 10.1016\/j.cpcardiol.2021.101042","journal-title":"Curr Probl Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)31340-3","article-title":"Assessment of contributing risk factors leading to heart failure in methamphetamine user patients","volume":"73","author":"Savoj J","year":"2019","unstructured":"Savoj J, Ayutyanont N, Vandever C, Gulati R, Biswas M. Assessment of contributing risk factors leading to heart failure in methamphetamine user patients. J Am Coll Cardiol. 2019, 73:732. 10.1016\/S0735-1097(19)31340-3","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and Stroke Statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin EJ","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, et al.. Heart disease and Stroke Statistics-2018 update: a report from the American Heart Association. Circulation. 2018, 137:e67-e492. 10.1161\/CIR.0000000000000558","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-015-9350-y","article-title":"Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence","volume":"16","author":"Sliman S","year":"2016","unstructured":"Sliman S, Waalen J, Shaw D. Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence. Cardiovasc Toxicol. 2016, 16:381-9. 10.1007\/s12012-015-9350-y","journal-title":"Cardiovasc Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger VL","year":"2004","unstructured":"Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004, 292:344-50. 10.1001\/jama.292.3.344","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.06.012","article-title":"Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy","volume":"3","author":"Shore S","year":"2015","unstructured":"Shore S, Grau-Sepulveda MV, Bhatt DL, et al.. Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy. JACC Heart Fail. 2015, 3:906-16. 10.1016\/j.jchf.2015.06.012","journal-title":"JACC Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He J","year":"2001","unstructured":"He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001, 161:996-1002. 10.1001\/archinte.161.7.996","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s1550-8579(08)80005-8","article-title":"Gender differences in methamphetamine use and responses: a review","volume":"5","author":"Dluzen DE","year":"2008","unstructured":"Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med. 2008, 5:24-35. 10.1016\/s1550-8579(08)80005-8","journal-title":"Gend Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14036","article-title":"Sex influences susceptibility to methamphetamine cardiomyopathy in mice","volume":"7","author":"Marcinko MC","year":"2019","unstructured":"Marcinko MC, Darrow AL, Tuia AJ, Shohet RV. Sex influences susceptibility to methamphetamine cardiomyopathy in mice. Physiol Rep. 2019, 7:e14036. 10.14814\/phy2.14036","journal-title":"Physiol Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.02.017","article-title":"Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy","volume":"5","author":"Sch\u00fcrer S","year":"2017","unstructured":"Sch\u00fcrer S, Klingel K, Sandri M, et al.. Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy. JACC Heart Fail. 2017, 5:435-45. 10.1016\/j.jchf.2017.02.017","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan TE","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355:251-9. 10.1056\/NEJMoa052256","journal-title":"N Engl J Med"},{"key":"ref20","unstructured":"Projections of cardiovascular disease prevalence and costs. 2015-2035. (2016). https:\/\/www.heart.org\/-\/media\/Files\/Get-Involved\/Advocacy\/CVD-Predictions-Through-2035.pdf."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-006-9152-0","article-title":"Drug use and medication adherence among HIV-1 infected individuals","volume":"11","author":"Hinkin CH","year":"2007","unstructured":"Hinkin CH, Barclay TR, Castellon SA, et al.. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007, 11:185-94. 10.1007\/s10461-006-9152-0","journal-title":"AIDS Behav"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158354-assessment-of-contributing-risk-factors-leading-to-heart-failure-in-patients-who-are-methamphetamine-users","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:01:03Z","timestamp":1735326063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158354-assessment-of-contributing-risk-factors-leading-to-heart-failure-in-patients-who-are-methamphetamine-users"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.76479","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}